Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Luxar Corporation was a pioneering medical device company that specialized in the development and manufacture of CO2 laser systems for surgical, dental, and aesthetic applications. The company was best known for its flexible fiber delivery systems, which provided high precision and maneuverability for soft tissue procedures. Its flagship products, including the NovaPulse and AccuVet laser systems, became industry standards in both human and veterinary medicine. Luxar was acquired by ESC Medical Systems (now known as Lumenis) in 1997, and its technology continues to influence the design of modern surgical lasers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Luxar.